Charles River Laboratories International (CRL) Other Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $138.3 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 29.15% year-over-year to $138.3 million; the TTM figure through Dec 2025 stood at $138.3 million (down 29.15% YoY), while the FY2025 annual figure was $138.3 million, down 29.15% from the prior year.
• Other Non-Current Liabilities was $138.3 million for Q4 2025 at Charles River Laboratories International, down from $189.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $242.9 million in Q4 2021 to a low of $138.3 million in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $201.8 million across 5 years, with a median of $195.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities jumped 37.19% in 2024, then retreated 29.15% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $242.9 million in 2021, then decreased by 28.02% to $174.8 million in 2022, then grew by 27.67% to $223.2 million in 2023, then declined by 12.54% to $195.2 million in 2024, then slipped by 29.15% to $138.3 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $138.3 million (Q4 2025), $189.5 million (Q3 2025), and $185.2 million (Q2 2025), per Business Quant data.